Applied Therapeutics, Inc.

NASDAQ:APLT

0.802 (USD) • At close January 7, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Operating Activities:
Net Income -68.5912.898-83.938-37.679-42.37-29.577-10.137-14.429-19.101-25.857-23.121-27.159-28.418-25.828-24.179-23.689-29.844-28.059-12.369-17.633-10.714-8.436-8.73-6.719-4.281-3.186-2.335
Depreciation & Amortization 0.3250.1220.1190.0060.1180.1160.1140.1140.1120.1090.1080.1070.1040.1040.10.0990.0950.0930.0930.0230000000
Deferred Income Tax 000-41.80327.66514.1380000000-0.990.992.55200000000000
Stock Based Compensation 2.0911.892.3791.6261.8361.8432.0551.9982.8562.2312.0772.8492.6452.7022.9812.5552.4031.7371.3311.3481.2193.2790.3250.0920.0780.0760.026
Change In Working Capital 5.951-4.814-1.1371.703-1.854-2.0880.7980.011-3.892-1.154-3.809-2.63410.105-1.795-2.008-4.176.74310.404-7.8233.8431.886-3.9021.4030.0271.2270.10.71
Accounts Receivables 000000000000000000000000000
Change In Inventory 000000000000000000000000000
Change In Accounts Payables 0.1540.4140.527-4.2631.318-0.8681.021-2.439-1.7182.769-3.5390.2915.86-0.1652.835-1.305-3.5894.049-7.1997.078-1.7890.828-0.3660.4691.7030.120.01
Other Working Capital 5.797-5.228-1.6645.966-3.172-1.22-1.0212.45-2.174-3.923-0.27-2.9254.245-1.63-4.843-2.86510.3326.355-0.624-3.2353.675-4.731.769-0.442-0.476-0.020.7
Other Non Cash Items 36.894-20.97165.75659.142-0.121-0.8840.18-3.5870.6356.2710.335-0.105-0.101-0.101-0.097-0.097-0.09-0.086-0.0870.012-0.230.83-0.3660.7310.9560.8480.468
Operating Cash Flow -23.33-22.595-18.911-17.005-14.726-16.452-6.99-15.893-19.39-18.4-24.41-26.942-15.665-25.908-22.213-22.75-20.693-15.911-18.855-12.407-7.839-9.059-7.002-5.869-2.02-2.162-1.131
Investing Activities:
Investments In Property Plant And Equipment 000000000000000000000000000
Acquisitions Net 000000000000000000000000000
Purchases Of Investments 0000000-27.307-21.924-8.993-5.994-12.47-14.573-6.539-88.007-7.101-109.89124.044-41.711-0.1280000000
Sales Maturities Of Investments 00000013.87220.40226.94514.52215.51924.27723.09123.31963.33535.54562.5360000000000
Other Investing Activites 00000013.872-6.9055.0215.5299.52511.8078.51816.78-24.67228.44417.10924.044-41.711-0.128-19.878000000
Investing Cash Flow 00000013.872-6.9055.0215.5299.52511.8078.51816.78-24.67228.444-30.24624.044-41.711-0.128-19.878000000
Financing Activities:
Debt Repayment 00-0.311-0.465-0.465-0.306-0.622-0.933-0.932-0.619-0.789-1.184-1.184-1.276-1.0742.148-1.0740000000005.56
Common Stock Issued -9.368-1.692106.7529.9086.71627.890-27.899-0.03927.89900.0010.104-0.00474.424-134.102-0.025-0.012134.13918.51037.23.1310000
Common Stock Repurchased 1.692-1.692000000-0.039000000000000000000
Dividends Paid 000000000000000000000000000
Other Financing Activities 00.319.0580.00310.3161.567000.0493.1050-0.0010.1044.7750.1360.945-0.1370.230.08-0.19-0.294-1.7512.9421.0560.0280.0090
Financing Cash Flow 0-1.692115.49729.44616.56729.151-0.622-0.933-0.97130.385-0.789-1.184-1.083.49573.4863.093-1.2360.218134.21918.32-0.29435.4492.9421.0560.0280.0095.56
Other Information:
Effect Of Forex Changes On Cash 000000000000000000000000000
Net Change In Cash -23.33-24.287109.02712.4411.84112.6996.26-23.731-15.3417.514-15.674-16.319-8.227-5.63326.6018.787-52.1758.35173.6535.785-28.01126.39-4.06215.187-1.992-2.1534.429
Cash At End Of Period 98.867122.197146.48449.89837.45735.61622.91716.65740.38855.72838.21453.88870.20778.43484.06757.46648.679100.85492.50318.8513.06541.07614.68618.7483.5615.5537.706